EPCAM and colorectal cancer: It was bound to maleimide-DTPA (as a chelating agent) and gadolinium (Gd) to create the anti-EpCAM-Gd-DTPA and proved to be an effective in vitro MRI contrast agent, specifically in the diagnosis of colorectal cancer and other EpCAM-positive tumors.